Receive a weekly summary and discussion of the top papers of the week by leading researchers in the field.

In Scientific reports ; h5-index 158.0

Alzheimer's disease (AD) is a common neurodegenerative disease with poor prognosis. New options for drug discovery targets are needed. We developed an imaging based arrayed CRISPR method to interrogate the human genome for modulation of in vitro correlates of AD features, and used this to assess 1525 human genes related to tau aggregation, autophagy and mitochondria. This work revealed (I) a network of tau aggregation modulators including the NF-κB pathway and inflammatory signaling, (II) a correlation between mitochondrial morphology, respiratory function and transcriptomics, (III) machine learning predicted novel roles of genes and pathways in autophagic processes and (IV) individual gene function inferences and interactions among biological processes via multi-feature clustering. These studies provide a platform to interrogate underexplored aspects of AD biology and offer several specific hypotheses for future drug discovery efforts.

Duan Lishu, Hu Mufeng, Tamm Joseph A, Grinberg Yelena Y, Shen Fang, Chai Yating, Xi Hualin, Gibilisco Lauren, Ravikumar Brinda, Gautam Vivek, Karran Eric, Townsend Matthew, Talanian Robert V

2021-Feb-03